Treasury yields edge lower ahead of PCE inflation report
Bond yields edged lower Friday as traders awaited a U.S. inflation report.
Bristol-Myers Squibb stock jumps on schizophrenia drug approval
Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.
Chinese stocks could surge higher as investors get ‘FOMO,’ Goldman Sachs says
International investors are getting increasingly concerned about missing out on the rally that was sparked by the unveiling of the People’s Bank of China’s far-reaching...
Mark Cuban voices interest in becoming the next SEC chair
Mark Cuban claims that Gensler is “awful” for crypto and all businesses Cuban highlighted Harris’s promise to advance technologies such as AI and blockchain Lawyer...
Satellite-TV rivals DirecTV, Dish reportedly in advanced merger talks
The Wall Street Journal reported DirecTV could acquire rival Dish, creating one of the nation’s largest pay-TV providers, in a deal that could be announced...
We’re upping our price target on Costco after another steady quarter fortifies our thesis
The retailer's fourth-quarter results were mixed, but we have more conviction in Costco's appeal to shoppers.
China ETFs set for best week on record after Beijing fires policy ‘bazooka’ to boost economy. Is it time to jump in?
China ETFs have surged on the back of a blitz of stimulus measures by the country’s government to revive the world’s second-largest economy.
Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims
Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged...
FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.